Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on May 1, 2025

Antalya wird zum Hotspot für Zahnreisen: Center Dental Clinic bietet Premium-Behandlungen mit über 70 % Ersparnis

Antalya wird zum Hotspot für Zahnreisen: Center Dental Clinic bietet Premium-Behandlungen mit über 70 % Ersparnis

ANTALYA, TURKEY, May 1, 2025 /⁨EINPresswire.com⁩/ -- Während Sonnenhungrige an den Stränden Antalyas entspannen, entdecken immer mehr Menschen die türkische Mittelmeerküste als Hotspot für hochqualitative Zahnbehandlungen. Die Center Dental Clinic …

Blue Sky Scrubs Introduces Sun-Kissed Style: A New Collection of Beach-Inspired Scrub Hats

Blue Sky Scrubs Introduces Sun-Kissed Style: A New Collection of Beach-Inspired Scrub Hats

Blue Sky Scrubs Unveils Sun-Kissed Style: A New Collection of Beach-Inspired Scrub Hats Celebrating 20+ Years of Handmade Luxury Medical Fashion AUSTIN, TX, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE Blue Sky Scrubs …

Leading Azerbaijani Physician Presents Definitive COVID-19 Volume at Cambridge University

Leading Azerbaijani Physician Presents Definitive COVID-19 Volume at Cambridge University

CAMBRIDGE, UNITED KINGDOM, May 1, 2025 /⁨EINPresswire.com⁩/ -- The historic halls of St Catharine's College, Cambridge University, welcomed the official U.K. launch of COVID-19: Disease of the Century, the groundbreaking new book by Prof. Lala …

Zanda Releases BizzyAI: Empowering Healthcare Professionals with Smart Session Transcription, Notes, & Writing Assist

Zanda Releases BizzyAI: Empowering Healthcare Professionals with Smart Session Transcription, Notes, & Writing Assist

BizzyAI makes it simple to transcribe sessions, dictate notes, and use AI actions to configure note drafts according to specific needs and writing styles. SALT LAKE CITY, UT, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Zanda, a top-rated practice …

Next-Generation Biomanufacturing Market Gathers Momentum: 8.5% CAGR Forecast Through 2035

Next-Generation Biomanufacturing Market Gathers Momentum: 8.5% CAGR Forecast Through 2035

Next-generation biomanufacturing market was valued at USD 24.1 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2025-2035 INDORE, INDIA, May 1, 2025 /⁨EINPresswire.com⁩/ -- The Next-generation biomanufacturing market …

Developers of Predictive Voice Test Announces 'Prescient Project' to Reduce Recruitment Cost of Dementia Clinical Trials

Developers of Predictive Voice Test Announces 'Prescient Project' to Reduce Recruitment Cost of Dementia Clinical Trials

Vivid Mind Provides an End-to-End Service for Recruitment of Patients in Hard-to-Catch, Initial Mild Cognitive Impairment (MCI) and Early Dementia Phases WARSAW, POLAND, May 1, 2025 /⁨EINPresswire.com⁩/ -- The century long quest for a cure for dementia …

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of approximately $65 million to supply the Ontario Ministry of Health with NARCAN® Nasal Spray for the …

Coherus to Participate in Upcoming Investor Conferences

Coherus to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life Science Conference in New York, NY …

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously disclosed in …

Premier Health Announces Results of Shareholders’ Meeting

Premier Health Announces Results of Shareholders’ Meeting

MONTRÉAL, May 01, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announces that all matters submitted to shareholders for approval were approved at its …

Precipio Announces Q1-2025 Shareholder Update Call

Precipio Announces Q1-2025 Shareholder Update Call

NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s …

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug …

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service